Phosphorylated α-synuclein immunoreactivity in the posterior pituitary lobe

Neuropathology

Volumn 32, Issue 4, 2012, Pages 385-389

  Homma, Taku ^a,b   Mochizuki, Yoko ^a   Mizutani, Toshio ^a  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

synucleinopathy; Lewy body related disorder; Parkinson's disease; Phosphorylated synuclein; Posterior pituitary lobe

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; AUTOPSY; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROHYPOPHYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY;

AGED; ALPHA-SYNUCLEIN; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODY DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE; PHOSPHORYLATION; PITUITARY GLAND, POSTERIOR; SENSITIVITY AND SPECIFICITY;

EID: 84864150557     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01273.x     Document Type: Article

References (16)

1. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839-840.
2. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 1992; 340: 186.
3. Duda JE. Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 2010; 289: 49-54.
4. Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997; 38 (Suppl 2): 2-7.
5. Braak H, de Vos RA, Bohl J, del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006; 396: 67-72.
6. Braak H, Sastre M, Bohl JR, de Vos RA, del Tredici K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007; 113: 421-429.
7. Dickson DW, Fujishiro H, DelleDonne A etal. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 2008; 115: 437-444.
8. Orimo S, Uchihara T, Nakamura A etal. Axonal α-synuclein aggregation herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008; 131: 642-650.
9. Braak H, Del Tredici K, Rub U etal. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
10. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
11. Fujiwara H, Hasegawa M, Dohmae N etal. α-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4: 160-164.
12. Sundquist J, Forsling ML, Olsson JE, Akerlund M. Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases. J Neurol Neurosurg Psychiatry 1983; 46: 14-17.
13. Purba JS, Hofman MA, Swaab DF. Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease. Neurology 1994; 44: 84-89.
14. Lightman SL, Forsling M. Evidence for dopamine as an inhibitor of vasopressin release in man. Clin Endoclinol 1980; 12: 39-46.
15. Colombo N, Berry I, Kucharczyk J etal. Posterior pituitary gland: Appearance on MR images in normal and pathologic states. Radiology 1987; 165: 481-485.
16. Kikuchi A, Takeda A, Okamura N etal. In vivo visualization of α-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy] benzoxazole positron emission tomography in multiple system atrophy. Brain 2010; 133: 1772-1778.